Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Interleukin-8 receptor antagonists in pulmonary diseases.
Hay DW, Sarau HM. Hay DW, et al. Curr Opin Pharmacol. 2001 Jun;1(3):242-7. doi: 10.1016/s1471-4892(01)00043-1. Curr Opin Pharmacol. 2001. PMID: 11712746 Review.
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
Salmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ, Slack RJ, Sarau HM, Palovich MR, Lainé DI, Hay DW, Rumsey WL. Salmon M, et al. Among authors: hay dw. J Pharmacol Exp Ther. 2013 May;345(2):260-70. doi: 10.1124/jpet.112.202051. Epub 2013 Feb 22. J Pharmacol Exp Ther. 2013. PMID: 23435542
Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.
Hay DW. Hay DW. Chest. 1997 Feb;111(2 Suppl):35S-45S. doi: 10.1378/chest.111.2_supplement.35s. Chest. 1997. PMID: 9042025 Review.
Cysteinyl leukotrienes in asthma: old mediators up to new tricks.
Hay DW, Torphy TJ, Undem BJ. Hay DW, et al. Trends Pharmacol Sci. 1995 Sep;16(9):304-9. doi: 10.1016/s0165-6147(00)89059-8. Trends Pharmacol Sci. 1995. PMID: 7482995 Review.
Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea.
Hay DW, Hubbard WC, Undem BJ. Hay DW, et al. Br J Pharmacol. 1993 Nov;110(3):955-62. doi: 10.1111/j.1476-5381.1993.tb13906.x. Br J Pharmacol. 1993. PMID: 7507780 Free PMC article.
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.
Sarau HM, Feild JA, Ames RS, Foley JJ, Nuthulaganti P, Schmidt DB, Buckley PT, Elshourbagy NA, Brawner ME, Luttmann MA, Giardina GA, Hay DW. Sarau HM, et al. Among authors: hay dw. Eur J Pharmacol. 2001 Feb 16;413(2-3):143-50. doi: 10.1016/s0014-2999(01)00732-4. Eur J Pharmacol. 2001. PMID: 11226387
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.
Giardina GA, Artico M, Cavagnera S, Cerri A, Consolandi E, Gagliardi S, Graziani D, Grugni M, Hay DW, Luttmann MA, Mena R, Raveglia LF, Rigolio R, Sarau HM, Schmidt DB, Zanoni G, Farina C. Giardina GA, et al. Among authors: hay dw. Farmaco. 1999 Jun 30;54(6):364-74. doi: 10.1016/s0014-827x(99)00043-9. Farmaco. 1999. PMID: 10443017
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC, Bochnowicz S, Osborn RR, Luttmann MA, Louden CS, Hart TK, Elliott JD, Hay DW. Underwood DC, et al. Among authors: hay dw. Pulm Pharmacol Ther. 1999;12(1):13-26. doi: 10.1006/pupt.1999.0158. Pulm Pharmacol Ther. 1999. PMID: 10208832
Cysteinyl leukotriene receptor assays.
Muccitelli RM, Luttmann MA, Hay DW. Muccitelli RM, et al. Among authors: hay dw. Curr Protoc Pharmacol. 2001 May;Chapter 4:Unit 4.16. doi: 10.1002/0471141755.ph0416s09. Curr Protoc Pharmacol. 2001. PMID: 22293965
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.
Sarau HM, Griswold DE, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Webb EF, Martin LD, Legos JJ, Whitmore RG, Barone FC, Medhurst AD, Luttmann MA, Giardina GA, Hay DW. Sarau HM, et al. Among authors: hay dw. J Pharmacol Exp Ther. 2000 Oct;295(1):373-81. J Pharmacol Exp Ther. 2000. PMID: 10992004
127 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback